Podcast Studio Glasgow

The Inside Matters Podcast — YouTube Review & H2 2026 Plan

Prepared for James McIlroy Covers 27 July 2025 – 27 July 2026 · YouTube only

Executive summary

This is a review of the last 12 months on YouTube, plus a proposed content plan for the second half of 2026. It's scoped to YouTube specifically — that's where the data is easiest to pull cleanly. A LinkedIn and Instagram view would need separate exports, and is worth doing once this is underway.

The short version: the flat months this year weren't a discovery problem, they were a publishing-frequency problem — every spike in views lines up with a batch of new uploads, and every quiet month lines up with silence. On top of that, a large share of the raw view count comes from an audience that scrolls past in under 30 seconds and doesn't stick around. Both are fixable, and the plan below leans on what's already proven to work: gut health content, weight loss, and athlete guests.

20,905Total views
720Hours watched
+98Net subscribers
133,695Impressions
3.18%Click-through rate

Key takeaways

  • 01Views track uploads, not luck.Every view spike this year lines up with a batch of new videos. 7 of the last 12 months had zero uploads — those are exactly the flattest months.
  • 02A lot of the view count is scroll-past, not audience-building.40% of views come from the Shorts feed, averaging 26 seconds watched. Search and external traffic are a smaller share but 5–10x deeper.
  • 03Subscriber conversion is under 0.5%.98 net subscribers from 20,905 views — this is the concrete number behind the "lots of posts, little growth" feeling.
  • 04Gut health/microbiome is still the core asset.44% of all views. The relaunch should build on this, not move away from it.
  • 05Weight loss and athlete content already outperform.Both run at 3.2–3.4x the channel average views per video — good evidence for where to lead in H2.
  • 06GLP-1 content is thin but has the best click-through rate on the channel.Only 3 videos so far, but 5.1% CTR says there's real appetite for it.

Why views happen

It's a publishing-frequency story

The chart below is monthly views across the last 12 months. The three tallest bars — including the one on the far right, still rising when this data was pulled — are the three months with fresh uploads. Everything else is back catalogue ticking over on its own.

Jul 25Aug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26

Bringing this to a fixed cadence — one shoot every few weeks instead of a burst followed by months of silence — is the single change likely to matter most in H2.

Where the views come from

YouTube doesn't split this per video, but the channel-wide picture explains the shape of the year:

Shorts feed
40%
of views — but only 4% of watch time. ~26 sec average.
YouTube search
29%
of views, 25% of watch time. ~2:41 average.
External links
15%
of views, 38% of watch time. ~5:12 average — the deepest of any source.

What's working

Topic performance, based on the last 12 months of activity:

TopicSignal
Gut health / microbiome44% of all views — the anchor
Athlete / performance3.4x channel average views
Weight loss3.2x channel average views
GLP-1Best CTR on the channel (5.1%)
Longevity & AITried at small scale, underperformed — needs a sharper angle, not more volume
TRT & peptidesNo videos yet — genuine white space
Thumbnails and titles are the fastest lever available: channel CTR sits at 3.18%, below YouTube's typical 4–10% healthy range, on content that's often landing well once someone clicks.

H2 2026 plan — 10 productions

A suggested running order for August–December, weighted toward what's already proven, with a few deliberate tests:

1
Weight lossFlagship opener — proven top performer
2
Athlete guestProven format, fix the thumbnail/title packaging
3
GLP-1sBest click-through rate on the channel — pair with weight loss
4
Gut health / microbiome drugsKeep the anchor topic running through the relaunch
5
Athlete guest #2Repeat the format, apply the packaging fix
6
TRTWhite space, closely adjacent audience — treat as a test
7
New developments in medicineWorks best as one sharp, specific story rather than a broad survey
8
PeptidesWhite space, natural pairing with TRT — treat as a test
9
LongevityRetry with a concrete angle, not a broad topic
10
AI in medicineNarrow to diagnostics/longevity specifically, not AI in general
Prepared by Podcast Studio Glasgow · hello@podcaststudioglasgow.com
Data source: YouTube Studio Analytics, 27 July 2025 – 27 July 2026.